Sanofi is selling a 50% stake in its Opella subsidiary, which includes Doliprane, to the American private equity firm CD&R, known for investing in unlisted companies since 1978. With an enterprise value of approximately 16 billion euros, CD&R aims to enhance Opella's growth and establish it as a leader in consumer healthcare. Sanofi will retain about 48% ownership, while Bpifrance is expected to acquire a small stake.
Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.
